Can "Awake Extracorporeal Life Support" Prevent Ventilator-Induced Diaphragm Atrophy and Injury in Patients with Acute on Chronic Respiratory Failure?
- Funded by Canadian Institutes of Health Research (CIHR)
- Total publications:5 publications
Grant number: 202104PJT
Grant search
Key facts
Disease
COVID-19Start & end year
20212024Known Financial Commitments (USD)
$241,740Funder
Canadian Institutes of Health Research (CIHR)Principal Investigator
N/A
Research Location
CanadaLead Research Institution
University Health NetworkResearch Priority Alignment
N/A
Research Category
Clinical characterisation and management
Research Subcategory
Supportive care, processes of care and management
Special Interest Tags
N/A
Study Type
Clinical
Clinical Trial Details
Not applicable
Broad Policy Alignment
Pending
Age Group
Unspecified
Vulnerable Population
Unspecified
Occupations of Interest
Unspecified
Abstract
The diaphragm is the main breathing muscle. Patients with diaphragm weakness experience serious difficulties with breathing and exercise. A strong diaphragm makes patients more resilient to acute respiratory problems and maintaining diaphragm strength in respiratory failure patients is vitally important to help patients recover from lung failure due to pneumonia, Covid-19, and other lung diseases. Being on a ventilator for lung failure can cause diaphragm weakness; this might be prevented by a different form of artificial lung support that avoids the need for the breathing machine. In patients who require artificial lung support before transplantation, we will study diaphragm tissue obtained during the transplant surgery to determine whether the use of artificial lung support can avoid the loss of diaphragm muscle bulk and reduce the amount of diaphragm muscle injury that occurs with the artificial breathing machine. Answers to these questions will lead to new methods for treating patients with lung failure focused on improving and maintaining diaphragm muscle bulk and strength. These methods will enable us to improve recovery and quality of life for patients with acute and chronic lung diseases.
Publicationslinked via Europe PMC
Last Updated:an hour ago
View all publications at Europe PMC